Investigating a specific type of prostate cancer to find new treatment options
A study of IDH1-mutant prostate cancer to identify novel therapeutic targets
This study is looking at a specific type of prostate cancer with a gene change that makes it tough to treat, and it's for patients with this mutation to help find better ways to manage their cancer and improve their treatment options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10947087 on NIH RePORTER |
What this research studies
This research focuses on a rare subtype of prostate cancer that has a mutation in the IDH1 gene, which appears to resist common therapies. The team will explore how this mutation affects the cancer's ability to adapt to treatment and will investigate potential new therapeutic targets to prevent therapy resistance. By studying a large group of patients with this mutation, the researchers aim to understand the underlying mechanisms and improve treatment outcomes for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with metastatic prostate cancer who have the IDH1 mutation.
Not a fit: Patients without the IDH1 mutation or those with other types of prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies that prevent resistance in prostate cancer patients with IDH1 mutations.
How similar studies have performed: Previous research has shown that targeting IDH1 mutations in other cancers has been promising, suggesting potential for success in this area as well.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Sena, Laura a. — Johns Hopkins University
- Study coordinator: Sena, Laura a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.